APO Research, Inc.

APO RESEARCH · REPORT

Acamprosate

Selected research

Industry Growth & Trends

Global Acamprosate Industry Growth and Trends Forecast to 2032

Market perspective

The global Acamprosate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Acamprosate include Teva, Merck Group, Mylan, Zydus Pharmaceuticals and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Acamprosate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Acamprosate market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acamprosate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acamprosate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Acamprosate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Acamprosate Market by Company

Teva

Merck Group

Mylan

Zydus Pharmaceuticals

Glenmark Pharmaceuticals

Acamprosate Segment by Type

333 mg Delayed Release Tablet

Others

Acamprosate Segment by Application

Hospital

Clinic

Others

Acamprosate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acamprosate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acamprosate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acamprosate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Acamprosate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Acamprosate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 333 mg Delayed Release Tablet Table 2. Major Company of Others Table 3. Global Acamprosate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Acamprosate Sales by Type (2021-2026) & (K Pcs) Table 5. Global Acamprosate Sales Market Share in Volume by Type (2021-2026) Table 6. Global Acamprosate Sales by Type (2021-2026) & (US$ Million) Table 7. Global Acamprosate Sales Market Share in Value by Type (2021-2026) Table 8. Global Acamprosate Price by Type (2021-2026) & (US$/Pcs) Table 9. Global Acamprosate Sales by Type (2027-2032) & (K Pcs) Table 10. Global Acamprosate Sales Market Share in Volume by Type (2027-2032) Table 11. Global Acamprosate Sales by Type (2027-2032) & (US$ Million) Table 12. Global Acamprosate Sales Market Share in Value by Type (2027-2032) Table 13. Global Acamprosate Price by Type (2027-2032) & (US$/Pcs) Table 14. North America Acamprosate Sales by Type (2021-2026) & (K Pcs) Table 15. North America Acamprosate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Acamprosate Sales by Type (2021-2026) & (K Pcs) Table 17. Europe Acamprosate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Acamprosate Sales by Type (2021-2026) & (K Pcs) Table 19. Asia-Pacific Acamprosate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Acamprosate Sales by Type (2021-2026) & (K Pcs) Table 21. Latin America Acamprosate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Acamprosate Sales by Type (2021-2026) & (K Pcs) Table 23. Middle East and Africa Acamprosate Sales by Type (2021-2026) & (US$ Million) Table 24. Acamprosate Industry Trends Table 25. Acamprosate Industry Drivers Table 26. Acamprosate Industry Opportunities and Challenges Table 27. Acamprosate Industry Restraints Table 28. Global Acamprosate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Acamprosate Revenue Market Share by Company (2021-2026) Table 30. Global Acamprosate Sales by Company (2021-2026) & (K Pcs) Table 31. Global Acamprosate Sales Share by Company (2021-2026) Table 32. Global Acamprosate Market Price by Company (2021-2026) & (US$/Pcs) Table 33. Global Acamprosate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Acamprosate Major Company Production Sites and Headquarters Table 35. Global Acamprosate Company, Product Type & Application Table 36. Global Acamprosate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Acamprosate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Acamprosate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Acamprosate Sales by Region (2021-2026) & (K Pcs) Table 41. Global Acamprosate Sales Market Share in Volume by Region (2021-2026) Table 42. Global Acamprosate Sales by Region (2021-2026) & (US$ Million) Table 43. Global Acamprosate Sales Market Share in Value by Region (2021-2026) Table 44. Global Acamprosate Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 45. Global Acamprosate Sales by Region (2027-2032) & (K Pcs) Table 46. Global Acamprosate Sales Market Share in Volume by Region (2027-2032) Table 47. Global Acamprosate Sales by Region (2027-2032) & (US$ Million) Table 48. Global Acamprosate Sales Market Share in Value by Region (2027-2032) Table 49. Global Acamprosate Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 50. Global Acamprosate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Acamprosate Sales by Application (2021-2026) & (K Pcs) Table 52. Global Acamprosate Sales Market Share in Volume by Application (2021-2026) Table 53. Global Acamprosate Sales by Application (2021-2026) & (US$ Million) Table 54. Global Acamprosate Sales Market Share in Value by Application (2021-2026) Table 55. Global Acamprosate Price by Application (2021-2026) & (US$/Pcs) Table 56. Global Acamprosate Sales by Application (2027-2032) & (K Pcs) Table 57. Global Acamprosate Sales Market Share in Volume by Application (2027-2032) Table 58. Global Acamprosate Sales by Application (2027-2032) & (US$ Million) Table 59. Global Acamprosate Sales Market Share in Value by Application (2027-2032) Table 60. Global Acamprosate Price by Application (2027-2032) & (US$/Pcs) Table 61. North America Acamprosate Sales by Application (2021-2026) & (K Pcs) Table 62. North America Acamprosate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Acamprosate Sales by Application (2021-2026) & (K Pcs) Table 64. Europe Acamprosate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Acamprosate Sales by Application (2021-2026) & (K Pcs) Table 66. Asia-Pacific Acamprosate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Acamprosate Sales by Application (2021-2026) & (K Pcs) Table 68. Latin America Acamprosate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Acamprosate Sales by Application (2021-2026) & (K Pcs) Table 70. Middle East and Africa Acamprosate Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Acamprosate Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 74. Teva Acamprosate Product Portfolio Table 75. Teva Recent Development Table 76. Merck Group Company Information Table 77. Merck Group Business Overview Table 78. Merck Group Acamprosate Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 79. Merck Group Acamprosate Product Portfolio Table 80. Merck Group Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Acamprosate Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 84. Mylan Acamprosate Product Portfolio Table 85. Mylan Recent Development Table 86. Zydus Pharmaceuticals Company Information Table 87. Zydus Pharmaceuticals Business Overview Table 88. Zydus Pharmaceuticals Acamprosate Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 89. Zydus Pharmaceuticals Acamprosate Product Portfolio Table 90. Zydus Pharmaceuticals Recent Development Table 91. Glenmark Pharmaceuticals Company Information Table 92. Glenmark Pharmaceuticals Business Overview Table 93. Glenmark Pharmaceuticals Acamprosate Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 94. Glenmark Pharmaceuticals Acamprosate Product Portfolio Table 95. Glenmark Pharmaceuticals Recent Development Table 96. North America Acamprosate Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 97. North America Acamprosate Sales by Country (2021-2026) & (K Pcs) Table 98. North America Acamprosate Sales Market Share by Country (2021-2026) Table 99. North America Acamprosate Sales Forecast by Country (2027-2032) & (K Pcs) Table 100. North America Acamprosate Sales Market Share Forecast by Country (2027-2032) Table 101. North America Acamprosate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Acamprosate Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Acamprosate Market Share by Country (2021-2026) Table 104. North America Acamprosate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Acamprosate Market Share Forecast by Country (2027-2032) Table 106. Europe Acamprosate Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 107. Europe Acamprosate Sales by Country (2021-2026) & (K Pcs) Table 108. Europe Acamprosate Sales Market Share by Country (2021-2026) Table 109. Europe Acamprosate Sales Forecast by Country (2027-2032) & (K Pcs) Table 110. Europe Acamprosate Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Acamprosate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Acamprosate Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Acamprosate Market Share by Country (2021-2026) Table 114. Europe Acamprosate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Acamprosate Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Acamprosate Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Acamprosate Sales by Country (2021-2026) & (K Pcs) Table 118. Asia-Pacific Acamprosate Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Acamprosate Sales Forecast by Country (2027-2032) & (K Pcs) Table 120. Asia-Pacific Acamprosate Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Acamprosate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Acamprosate Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Acamprosate Market Share by Country (2021-2026) Table 124. Asia-Pacific Acamprosate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Acamprosate Market Share Forecast by Country (2027-2032) Table 126. Latin America Acamprosate Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 127. Latin America Acamprosate Sales by Country (2021-2026) & (K Pcs) Table 128. Latin America Acamprosate Sales Market Share by Country (2021-2026) Table 129. Latin America Acamprosate Sales Forecast by Country (2027-2032) & (K Pcs) Table 130. Latin America Acamprosate Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Acamprosate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Acamprosate Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Acamprosate Market Share by Country (2021-2026) Table 134. Latin America Acamprosate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Acamprosate Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Acamprosate Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Acamprosate Sales by Country (2021-2026) & (K Pcs) Table 138. Middle East and Africa Acamprosate Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Acamprosate Sales Forecast by Country (2027-2032) & (K Pcs) Table 140. Middle East and Africa Acamprosate Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Acamprosate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Acamprosate Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Acamprosate Market Share by Country (2021-2026) Table 144. Middle East and Africa Acamprosate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Acamprosate Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Acamprosate Distributors List Table 149. Acamprosate Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Acamprosate Image Figure 2. Global Acamprosate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acamprosate Market Size (2021-2032) & (US$ Million) Figure 4. Global Acamprosate Sales (2021-2032) & (K Pcs) Figure 5. 333 mg Delayed Release Tablet Image Figure 6. Global 333 mg Delayed Release Tablet Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. Others Image Figure 8. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. Global Acamprosate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Acamprosate Market Share by Type 2025 VS 2032 Figure 11. North America Acamprosate Sales Market Share in Volume by Type in 2025 Figure 12. North America Acamprosate Sales Market Share in Value by Type in 2025 Figure 13. Europe Acamprosate Sales Market Share in Volume by Type in 2025 Figure 14. Europe Acamprosate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Acamprosate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Acamprosate Sales Market Share in Value by Type in 2025 Figure 17. Latin America Acamprosate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Acamprosate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Acamprosate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Acamprosate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Acamprosate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Pcs) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Pcs) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Global Acamprosate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Acamprosate Market Share by Application 2025 VS 2032 Figure 31. North America Acamprosate Sales Market Share in Volume by Application in 2025 Figure 32. North America Acamprosate Sales Market Share in Value by Application in 2025 Figure 33. Europe Acamprosate Sales Market Share in Volume by Application in 2025 Figure 34. Europe Acamprosate Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Acamprosate Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Acamprosate Sales Market Share in Value by Application in 2025 Figure 37. Latin America Acamprosate Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Acamprosate Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Acamprosate Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Acamprosate Sales Market Share in Value by Application in 2025 Figure 41. North America Acamprosate Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 42. North America Acamprosate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Acamprosate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Acamprosate Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Acamprosate Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 46. Europe Acamprosate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Acamprosate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Acamprosate Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Acamprosate Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 50. Asia-Pacific Acamprosate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Acamprosate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Acamprosate Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Acamprosate Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 54. Latin America Acamprosate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Acamprosate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Acamprosate Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Acamprosate Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. Middle East and Africa Acamprosate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Acamprosate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Acamprosate Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Acamprosate Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Acamprosate Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 333 mg Delayed Release Tablet
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Merck Group
  • Mylan
  • Zydus Pharmaceuticals
  • Glenmark Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acamprosate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Acamprosate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Acamprosate Market by Type
  6. 1.3.1 333 mg Delayed Release Tablet
  7. 1.3.2 Others
  8. 1.4 Global Acamprosate Market Size by Type
  9. 1.4.1 Global Acamprosate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Acamprosate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Acamprosate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Acamprosate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Acamprosate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Acamprosate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Acamprosate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Acamprosate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Acamprosate Industry Trends
  2. 2.2 Acamprosate Industry Drivers
  3. 2.3 Acamprosate Industry Opportunities and Challenges
  4. 2.4 Acamprosate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Acamprosate Revenue (2021-2026)
  2. 3.2 Global Top Players by Acamprosate Sales (2021-2026)
  3. 3.3 Global Top Players by Acamprosate Price (2021-2026)
  4. 3.4 Global Acamprosate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Acamprosate Major Company Production Sites & Headquarters
  6. 3.6 Global Acamprosate Company, Product Type & Application
  7. 3.7 Global Acamprosate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Acamprosate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Acamprosate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Acamprosate Tier 1, Tier 2, and Tier 3
4 Acamprosate Regional Status and Outlook
  1. 4.1 Global Acamprosate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Acamprosate Historic Market Size by Region
  3. 4.2.1 Global Acamprosate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Acamprosate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Acamprosate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Acamprosate Forecasted Market Size by Region
  7. 4.3.1 Global Acamprosate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Acamprosate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Acamprosate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Acamprosate by Application
  1. 5.1 Acamprosate Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Acamprosate Market Size by Application
  6. 5.2.1 Global Acamprosate Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Acamprosate Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Acamprosate Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Acamprosate Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Acamprosate Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Acamprosate Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Acamprosate Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Acamprosate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Acamprosate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Acamprosate Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Merck Group
  8. 6.2.1 Merck Group Company Information
  9. 6.2.2 Merck Group Business Overview
  10. 6.2.3 Merck Group Acamprosate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Group Acamprosate Product Portfolio
  12. 6.2.5 Merck Group Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Acamprosate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Acamprosate Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Zydus Pharmaceuticals
  20. 6.4.1 Zydus Pharmaceuticals Company Information
  21. 6.4.2 Zydus Pharmaceuticals Business Overview
  22. 6.4.3 Zydus Pharmaceuticals Acamprosate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zydus Pharmaceuticals Acamprosate Product Portfolio
  24. 6.4.5 Zydus Pharmaceuticals Recent Developments
  25. 6.5 Glenmark Pharmaceuticals
  26. 6.5.1 Glenmark Pharmaceuticals Company Information
  27. 6.5.2 Glenmark Pharmaceuticals Business Overview
  28. 6.5.3 Glenmark Pharmaceuticals Acamprosate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Glenmark Pharmaceuticals Acamprosate Product Portfolio
  30. 6.5.5 Glenmark Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Acamprosate Sales by Country
  2. 7.1.1 North America Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Acamprosate Sales by Country (2021-2026)
  4. 7.1.3 North America Acamprosate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Acamprosate Market Size by Country
  6. 7.2.1 North America Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Acamprosate Market Size by Country (2021-2026)
  8. 7.2.3 North America Acamprosate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Acamprosate Sales by Country
  2. 8.1.1 Europe Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Acamprosate Sales by Country (2021-2026)
  4. 8.1.3 Europe Acamprosate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Acamprosate Market Size by Country
  6. 8.2.1 Europe Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Acamprosate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Acamprosate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Acamprosate Sales by Country
  2. 9.1.1 Asia-Pacific Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Acamprosate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Acamprosate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Acamprosate Market Size by Country
  6. 9.2.1 Asia-Pacific Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Acamprosate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Acamprosate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Acamprosate Sales by Country
  2. 10.1.1 South America Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Acamprosate Sales by Country (2021-2026)
  4. 10.1.3 South America Acamprosate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Acamprosate Market Size by Country
  6. 10.2.1 South America Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Acamprosate Market Size by Country (2021-2026)
  8. 10.2.3 South America Acamprosate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Acamprosate Sales by Country
  2. 11.1.1 Middle East and Africa Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Acamprosate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Acamprosate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Acamprosate Market Size by Country
  6. 11.2.1 Middle East and Africa Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Acamprosate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Acamprosate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Acamprosate Value Chain Analysis
  2. 12.1.1 Acamprosate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Acamprosate Production Mode & Process
  7. 12.2 Acamprosate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Acamprosate Distributors
  10. 12.2.3 Acamprosate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.